| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 137, 871-882, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
RH Hruban, WE Beschorner, WA Baumgartner, SM Augustine, H Ren, BA Reitz and GM Hutchins
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Accelerated arteriosclerosis has emerged as a major life-threatening complication in long-term survivors of heart transplantation. It has been proposed that accelerated arteriosclerosis is an immune-mediated complication of rejection. We observed a striking endothelialitis in the coronary arteries of two explanted hearts obtained from patients with severe transplant-related accelerated arteriosclerosis. This finding prompted us to review the pathologic changes in the coronary arteries of 23 autopsied patients who had received heart transplants. The infiltrate in these vessels was characterized using immunohistochemical stains for lymphocytes (CD45), macrophages (MAC- 387), T lymphocytes (CD45RO), B lymphocytes (L-26), and smooth muscle cells (actin). In addition, a full panel of monoclonal antibodies was used on the fresh-frozen tissue available from one of the two explanted hearts. Ten of the eleven recipients with accelerated arteriosclerosis had a moderate to marked lymphocytic endothelialitis compared to 3 of 14 without transplant-related arteriosclerosis (P less than 0.005). Immunohistochemical staining of the paraffin-embedded material demonstrated that most of the lymphocytes in the subendothelial space of these vessels were T lymphocytes and that this infiltrate was associated with an accumulation of macrophages and a proliferation of smooth muscle cells in the intima. In the explanted heart from which fresh-frozen tissue was available for more detailed cell typing, the T cells marked predominantly as cytotoxic T lymphocytes (CD8+, CD2+). These results suggest that accelerated arteriosclerosis may be mediated, in part, by a cytotoxic T-lymphocyte-directed endothelialitis.
This article has been cited by other articles:
 |
|
 |
|
  B. P. Griffith, M. Haddad, and R. S. Poston Immunobiology of Heart and Heart-Lung Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1513 - 1538. [Full Text]
|
|
|
|
 |
|
 C. Schmidt-Lucke, A. Aicher, P. Romagnani, B. Gareis, S. Romagnani, A. M. Zeiher, and S. Dimmeler Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2425 - H2431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Mitchell and P. Libby Vascular Remodeling in Transplant Vasculopathy Circ. Res., April 13, 2007; 100(7): 967 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Mason, R. Steinberg, E. A. Lidington, A. R. Kinderlerer, M. Ohba, and D. O. Haskard Decay-accelerating Factor Induction on Vascular Endothelium by Vascular Endothelial Growth Factor (VEGF) Is Mediated via a VEGF Receptor-2 (VEGF-R2)- and Protein Kinase C-{alpha}/{epsilon} (PKC{alpha}/{epsilon})-dependent Cytoprotective Signaling Pathway and Is Inhibited by Cyclosporin A J. Biol. Chem., October 1, 2004; 279(40): 41611 - 41618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Saiura, M. Sata, K.-i. Hiasa, S. Kitamoto, M. Washida, K. Egashira, R. Nagai, and M. Makuuchi Antimonocyte Chemoattractant Protein-1 Gene Therapy Attenuates Graft Vasculopathy Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1886 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Choy, A. Kerjner, B. W. Wong, B. M. McManus, and D. J. Granville Perforin Mediates Endothelial Cell Death and Resultant Transplant Vascular Disease in Cardiac Allografts Am. J. Pathol., July 1, 2004; 165(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ii and D. W. Losordo Transplant Graft Vasculopathy: A Dark Side of Bone Marrow Stem Cells? Circulation, December 23, 2003; 108(25): 3056 - 3058. [Full Text] [PDF]
|
|
|
|
|
|
K. Shimizu, M. Aikawa, K. Takayama, P. Libby, and R. N. Mitchell Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins Circulation, October 28, 2003; 108(17): 2113 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Hillebrands, F. A. Klatter, and J. Rozing Origin of Vascular Smooth Muscle Cells and the Role of Circulating Stem Cells in Transplant Arteriosclerosis Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 380 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Griffith and R. S. Poston Immunobiology of Heart and Heart-Lung Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1403 - 1426. [Full Text]
|
|
|
|
|
|
S. M. Hollenberg, L. W. Klein, J. E. Parrillo, M. Scherer, D. Burns, P. Tamburro, M. Oberoi, M. R. Johnson, and M. R. Costanzo Coronary Endothelial Dysfunction After Heart Transplantation Predicts Allograft Vasculopathy and Cardiac Death Circulation, December 18, 2001; 104(25): 3091 - 3096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sata, Z. Luo, and K. Walsh Fas Ligand Overexpression on Allograft Endothelium Inhibits Inflammatory Cell Infiltration and Transplant-Associated Intimal Hyperplasia J. Immunol., June 1, 2001; 166(11): 6964 - 6971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Slachta, V. Jeevanandam, B. Goldman, W. L. Lin, and C. D. Platsoucas Coronary Arteries from Human Cardiac Allografts with Chronic Rejection Contain Oligoclonal T Cells: Persistence of Identical Clonally Expanded TCR Transcripts from the Early Post-Transplantation Period (Endomyocardial Biopsies) to Chronic Rejection (Coronary Arteries) J. Immunol., September 15, 2000; 165(6): 3469 - 3483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Holvoet, J. Van Cleemput, D. Collen, and J. Vanhaecke Oxidized Low Density Lipoprotein Is a Prognostic Marker of Transplant-Associated Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 698 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Furukawa, G. Becker, J. L. Stinn, K. Shimizu, P. Libby, and R. N. Mitchell Interleukin-10 (IL-10) Augments Allograft Arterial Disease : Paradoxical Effects of IL-10 in Vivo Am. J. Pathol., December 1, 1999; 155(6): 1929 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. R. Baker, R. J. C. Hall, T. J. Evans, A. Pomerance, J. Maclouf, C. Creminon, M. H. Yacoub, and J. M. Polak Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particularly in Macrophages Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 646 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hasegawa, G. Becker, H. Nagano, P. Libby, and R. N. Mitchell Pattern of Graft- and Host-Specific MHC Class II Expression in Long-Term Murine Cardiac Allografts : Origin of Inflammatory and Vascular Wall Cells Am. J. Pathol., July 1, 1998; 153(1): 69 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders Blood, May 15, 1998; 91(10): 3527 - 3561. [Full Text] [PDF]
|
|
|
|
|
|
P. Holvoet, J.-M. Stassen, J. Van Cleemput, D. Collen, and J. Vanhaecke Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 100 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Amano, S. Ishiyama, T. Nishikawa, H. Tanaka, R. Nagai, F. Marumo, and M. Hiroe PROLIFERATION OF SMOOTH MUSCLE CELLS IN ACUTE ALLOGRAFT VASCULAR REJECTION J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 19 - 25. [Abstract] [Full Text]
|
|
|
|
|
|
K. B. Lemstrom, A. K. Raisanen-Sokolowski, P. J. Hayry, and P. K. Koskinen Triple Drug Immunosuppression Significantly Reduces Aortic Allograft Arteriosclerosis in the Rat Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 553 - 564. [Abstract] [Full Text]
|
|
|
|
|
|
S. F. Davis, A. C. Yeung, I. T. Meredith, F. Charbonneau, P. Ganz, A. P. Selwyn, and T. J. Anderson Early Endothelial Dysfunction Predicts the Development of Transplant Coronary Artery Disease at 1 Year Posttransplant Circulation, February 1, 1996; 93(3): 457 - 462. [Abstract] [Full Text]
|
|
|
|
|
|
T. Nakagawa, G. K. Sukhova, E. Rabkin, G. L. Winters, F. J. Schoen, and P. Libby Acute Rejection Accelerates Graft Coronary Disease in Transplanted Rabbit Hearts Circulation, August 15, 1995; 92(4): 987 - 993. [Abstract] [Full Text]
|
|
|
|
|
|
A. Ardehali, H. Laks, D. C. Drinkwater, E. Ziv, and T. A. Drake Vascular Cell Adhesion Molecule–1 Is Induced on Vascular Endothelia and Medial Smooth Muscle Cells in Experimental Cardiac Allograft Vasculopathy Circulation, August 1, 1995; 92(3): 450 - 456. [Abstract] [Full Text]
|
|
|
|
|
|
G. L. Winters, E. Loh, and F. J. Schoen Natural History of Focal Moderate Cardiac Allograft Rejection : Is Treatment Warranted? Circulation, April 1, 1995; 91(7): 1975 - 1980. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Tuzcu, R. E. Hobbs, G. Rincon, C. Bott-Silverman, A. C. De Franco, K. Robinson, P. M. McCarthy, R. W. Stewart, S. Guyer, and S. E. Nissen Occult and Frequent Transmission of Atherosclerotic Coronary Disease With Cardiac Transplantation : Insights From Intravascular Ultrasound Circulation, March 15, 1995; 91(6): 1706 - 1713. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
